Tolvaptan for the Management of Acute Decompensated Heart Failure in Patients With Advanced or Refractory Heart Failure
Phase of Trial: Phase IV
Latest Information Update: 04 May 2017
At a glance
- Drugs Tolvaptan (Primary)
- Indications Heart failure; Hyponatraemia
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 23 Jan 2017 Planned End Date changed from 1 Dec 2017 to 1 Oct 2018.
- 23 Jan 2017 Planned primary completion date changed from 1 Oct 2017 to 1 Mar 2018.